Arno Therapeutics, Inc 5
5 · Arno Therapeutics, Inc · Filed Feb 17, 2015
Insider Transaction Report
Form 5
HAMILTON WILLIAM F PHD
Director
Transactions
- Disposition to Issuer
2013 Series E Warrants (right to buy)
2014-10-28−20,833→ 0 totalExercise: $2.40From: 2013-10-29Exp: 2014-10-31→ Common Stock (20,833 underlying) - Award
2013 Series E Warrants (right to buy)
2014-10-28+20,833→ 20,833 totalExercise: $2.40From: 2013-10-29Exp: 2015-01-31→ Common Stock (20,833 underlying)
Holdings
- 22,079
Common Stock
Footnotes (1)
- [F1]The reported transaction resulted from the Issuer's unilateral extension of the expiration date of the outstanding warrant from 10/31/14 to 1/31/15. Such extension resulted in the deemed cancellation of the "originally" issued old warrant and the issuance of a replacement warrant. The Series E warrant was originally granted on 10/29/13.